Drug dealers are using food delivery services to traffic substances amid the coronavirus pandemic, police say.
Nearly half of the world's workforce is at immediate risk of losing their livelihood because of coronavirus, the International Labour Organization warned on Wednesday.
The continued sharp decline in working hours, as well as lockdown measures due to the outbreak means that 1.6 billion informal economy workers around the world “stand in immediate danger of having their livelihoods destroyed,” according to the organization's analysis. “For millions of workers, no income means no food, no security and no future. As the pandemic and the jobs crisis evolve, the need to protect the most vulnerable becomes even more urgent," the U.N. agency’s director general, Guy Ryder, told a briefing on Wednesday.is being felt hardest by informal workers and by enterprises in high-risk sectors.
It has exposed the frailties and inequalities of our societies. We must build a better normal that supports the most vulnerable first.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Coronavirus Drug Shows Promising Results, According to Drug MakerRemdesivir Shows Promising Results as a Coronavirus Treatment, According to Drug Manufacturer Gilead
Consulte Mais informação »
Why a Common Heartburn Drug Is Being Studied as a Possible Coronavirus TreatmentWhy a Heartburn Drug Is Being Studied as a COVID-19 Treatment, According to Doctors
Consulte Mais informação »
Cramer: Promising data from coronavirus drug trial 'beginning of the end of the true nightmare'CNBC's Jim Cramer said Wednesday that positive news from Gilead Sciences about a potential treatment for the coronavirus marked a turning point in the fight against Covid-19.
Consulte Mais informação »
Futures jump after Gilead's COVID-19 drug meets main goalU.S. stock index futures jumped on Wednesday after Gilead Sciences said its experimental antiviral drug met the main goal of a trial testing it in COVID-19 patients.
Consulte Mais informação »
Gilead reports 'positive data' on remdesivir coronavirus drug trial
Consulte Mais informação »